Decreased FOXP3 expression in small airways of smokers with COPD

European Respiratory Journal

Volumn 33, Issue 1, 2009, Pages 61-67

  Isajevs, S ^a   Taivans, I ^a   Strazda, G ^a   Kopeika, U ^b   Bukovskis, M ^b   Gordjusina, V ^a   Kratovska, A ^a  

^a UNIVERSITY OF LATVIA   (Latvia)

^b PAULS STRADINS CLINICAL UNIVERSITY HOSPITAL   (Latvia)

Author keywords

Chronic obstructive pulmonary disease; FOXP3 T regulatory cells; Inflammation

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; AIRWAY; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG FUNCTION; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SMOKING; UPREGULATION;

AGED; BRONCHI; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 58849142042     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00145307     Document Type: Article

References (30)

1. Pauwels RA, Buist AS, Calverey MA, Jenkins CR, Hurd SS. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2001; 163: 1256-1276.
2. Saetta M, Turato G, Maestrelli P, Mapp CE, Fabbri LM. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1304-1309.
3. Saetta M, Di Stefano A, Mastrelli P. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis 1993; 147: 301-306.
4. Lams BEA, Sousa AR, Rees PJ, Lee TH. Subepithelial immunopathology of large airways in smokers with and without chronic obstructive pulmonary disease. Eur Respir J 2000; 15: 512-516.
5. Di Stefano A, Caramori G, Oates T, et al. Increased expression of nuclear factor-κB in bronchial biopsies from smokers and patients with COPD. Eur Respir J 2002; 20: 556-563.
6. Dijaco C, Duftner C, Grubeck-Loebenstein B, Schirmer M. Imbalance of regulatory T cells in human autoimmune diseases. Immunol 2006; 117: 289.
7. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol 2005; 6: 338-344.
8. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005; 6: 345-352.
9. Tang Q, Bluestone JA. The Foxp3+ regulatory T cell: a jack of all trades,master of regulation. Nat Immunol 2008; 9: 239-244.
10. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057-1061.
11. Garside P, McIMowat A, Khoruts A. Oral tolerance in disease. Gut 1999; 44: 137-142.
12. Strober W, Kelsall B, Marth T. Oral tolerance. J Clin Immunol 1998; 18: 1-30.
13. Roncarolo MG, Levings MK. The role of different subsets of T regulatory cells in controlling autoimmunity. Curr Opin Immunol 2000; 12: 676-683.
14. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001; 2: 816-822.
15. Zhang L, Zhao Y. The regulation of Foxp3 expression in regulatory CD4+CD25+T cells: Multiple pathways on the road. J Cell Physiol 2007; 211: 590-597.
16. Taraseviciene-Stewart L, Scerbavicius R, Choe KH, et al. An animal model of autoimmune emphysema. Am J Respir Crit Care Med 2005; 171: 734-742.
17. van der Strate BW, Postma DS, Brandsma CA, et al. Cigarette smoke-induced emphysema: a role for the B cell? Am J Respir Crit Care Med 2006; 173: 751-758.
18. Lee SH, Goswami S, Grudo A, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007; 13: 567-569.
19. Feghali-Bostwick CA, Gadgil AS, Otterbein LE, et al. Autoantibodies in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177: 156-163.
20. Koethe SM, Kuhnmuench JR, Becker CG. Neutrophil priming by cigarette smoke condensate and a tobacco anti-idiotypic antibody. Am J Pathol 2000; 157: 1735-1743.
21. Smyth LJC, Starkey C, Vestbo J, Singh D. CD4-regulatory cells in COPD patients. Chest 2007; 132: 156-163.
22. Barcelo B, Pons J, Ferrer JM, Sauleda J, Fuster A, Agusti AGN. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking. Eur Respir J 2008; 31: 585-562.
23. BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997; 52: Suppl. 5, S1-S28.
24. Cosio MG. Autoimmunity, T-cells and STAT-4 in the pathogenesis of chronic obstructive pulmonary disease. Eur Respir J 2004; 24: 3-5.
25. Baraldo S, Saetta M. To reg or not to reg: that is the question in COPD. Eur Respir J 2008; 31: 486-488.
26. Pons J, Sauleda J, Ferrer JM, et al. Blunted δγ T-lymphocyte response in chronic obstructive pulmonary disease. Eur Respir J 2005; 25: 441-446.
27. Kuhn R, Lohler J, Rennick D. Interleukin-10 deficient mice develop inflammatory bowel disease in T cell receptor mutant mice. Cell 1993; 75: 263-274.
28. Black PN, Ching PST, Beaumount B, Ranasighe S, Taylor G, Merrilees MJ. Changes in elastic fibres in the small airways and alveoli in COPD. Eur Respir J 2008; 31: 998-1004.
29. Cerami C, Founds H, Nicholl I, et al. Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci 1997; 94: 13915-13920.
30. Robbins GS, Dawe DE, Goncharova SI, et al. Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness. Am J Respir Cell Mol Biol 2004; 30: 202-211.